- Treatment of Classic Kaposi's Sarcoma Showing a Discretely Scattered Distribution with Intralesional Vinblastine Injections
-
Kim BR, Park JT, Byun SY, Kwon SH, Huh CH
- KMID: 2429493
- Ann Dermatol.
- 2016 Feb;28(1):113-114.
- doi: 10.5021/ad.2016.28.1.113
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of M-VAC(Methotrexate, Vinblastine, Adriamycin and Cisplatin) Chemotherapy in Locally Invasiue T3a/T3b) Transitional Cell Carcinoma of the Bladder
-
Yoon HN, Chae SG, Jeon HS, Park WS, Choi HR, Yoon HS
- KMID: 2290277
- Korean J Urol.
- 1998 Dec;39(12):1217-1221.
PURPOSE: Since a significant number of patients with locally invasive bladder tumor(T3a/T3b) subsequently develop distant metastases, there have been lots of controversies in deciding treatment modalities. In the past decade,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Inappropriate ADH Secretion Secondary to Vinblastine Therapy
-
Park EH, Cho HS, Yoo HS, Lyu CJ, Yang CH, Kim KY
- KMID: 2104416
- J Korean Pediatr Soc.
- 1998 Oct;41(10):1430-1432.
Inappropriate secretion of antidiuretic hormone (ADH) secondary to vincristine therapy has been reported frequently. But there has been five previous reports of vinblastine associated SIADH in the world and in... -
- CITED
-
- Close
- SHARE
-
- Close
- Postoperative Sequential Mitomycin-C, Vinblastine, and Cisplatin (MVP) Chemotherapy and Radiotherapy for Resected Stage II-IIIA Non-small Cell Lung Cancer
-
Kim TW, Lee JS, Jung BH, Yun HJ, Zang DY, Lee JH, Kim SB, Kim SW, Suh C, Lee KH, Kim WK, Kim WD, Kim JH, Choi EK, Chang H, Kim DK, Park SI, Sohn KH, Kim SH
- KMID: 2251441
- Korean J Med.
- 1998 May;54(5):607-614.
OBJECTIVES: The poor survival rates among patients receiving surgery alone for stages II and III non-small cell lung cancer prompted several trials of adjuvant therapy after resection. We performed a... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Neoadjuvant Chemotherapy with 5-Fluorouracil (5-FU), Vinblastine and Cisplatin (FVP) for Stage III Non-Small Cell Lung Cancer (NSCLC)
-
Won JI, Chun JH, Kim HJ, Jo MS, Kim DK, Kwak YT, Kim JS, Choi SJ, Kim SR
- KMID: 2059148
- J Korean Cancer Assoc.
- 1997 Oct;29(5):807-815.
PURPOSE: As the prognosis of stage III NSCLC is still poor with or without operation, we conducted a phase II trial of neoadjuvant chemotherapy (CHT) with 5-FU, vinblastine, cisplatin prior... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Medroxyprogesterone Acetate On Cytotoxicity of Vinblastine in Renal Cell Carcinoma Cell Lines
-
Lee DH, Chung BH, Hong SJ
- KMID: 1914473
- Korean J Urol.
- 1997 Jan;38(1):1-6.
Inadequate effectiveness of anticancer drug in treating renal cell carcinoma has been attributed to the overexpression of multidrug resistance gene (MDR1) and its product, membrane-bound P-glycoprotein. P-glycoprotein is known to... -
- CITED
-
- Close
- SHARE
-
- Close
- Neoadjuvant M-VAC (Methotrexate, Vinblastine, Adriamycin and Cisplatin) Effect on the Invasive Bladder Tumor
-
Oh JH, Ryu SB
- KMID: 2290086
- Korean J Urol.
- 1996 Mar;37(3):293-300.
We evaluated the effect of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in 63 patients with invasive transitional cell carcinoma of the bladder between January 1987 and December 1993. The... -
- CITED
-
- Close
- SHARE
-
- Close
- M-VAC(Methotrexate, Vinblastine, Doxorubicin and Cisplatinum) Chemotherapy for Metastatic Transitional Cell Carcinoma
-
Sin CC, Chang SG, Kim JI
- KMID: 2139365
- Korean J Urol.
- 1995 May;36(5):502-506.
We treated 23 patients with metastatic transitional cell carcinoma with methotrexate, vinblastine, doxorubicin and cisplatinum(M-VAC) chemotherapy from March 1989 to June 1994. The mean age of the patients was 60.0... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Verapamil and Cyclosporin A on Cytotoxic Effect of Vinblastine upon Human Renal Cell Carcinoma Cell Lines
-
Kim HG, Kim HH, Lee C
- KMID: 1913987
- Korean J Urol.
- 1995 Mar;36(3):231-240.
It is well known that renal cell carcinoma shows poor responses upon chemotherapy, and a multidrug-resistance has been suggested as one of the possible mechanisms of their resistances to chemotherapeutics... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Mitomycin-c, Vinblastine, and Cisplatin(MVP) Combined Chemotherapy in Non-Small Cell Lung Cancer
-
Kim YW, Park NH, Ji SK, Choi HM, Lee SH, Lee KH, Jang TW, Jung MH
- KMID: 2045055
- Tuberc Respir Dis.
- 1995 Feb;42(1):76-83.
- doi: 10.4046/trd.1995.42.1.76
BACKGROUND: Despite advances in chemotherapy, the treatment of inoperable non-small cell carcinoma of the lung remains poor. According to the recent reports, the response rates of mitomycin, vinblastine, and cisplatin(MVP)... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of adjuvant M-VAC(methtrexate, vinblastine, doxorubicin and cisplatin) chemotherapy on advanced transitional cell carcinoma of the upper urinary tract
-
Seo BW, Ha DB, Park CH, Lee SC
- KMID: 2060396
- Korean J Urol.
- 1992 Aug;33(4):632-636.
We treated 11 patients with advanced transitional cell carcinoma of upper urinary tract with adjuvant M-VAC chemotherapy and their median survival time was compared with 9 patients without M-VAC chemotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of combination therapy with vinblastine, adriamycin and interferon-alpha, gamma on human renal cell carcinoma cell lines
-
Lee ES, Kim HH, Ahn HJ, Min KJ, Lee C
- KMID: 2060393
- Korean J Urol.
- 1992 Aug;33(4):611-617.
In vitro study was performed to evaluate the effect of combination therapy with vinblastine. adriamycin and interferon-alpha, gamma on human renal cell carcinoma cell lines. Three renal cell carcinoma cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Palliative chemotherapy of soft tissue sarcoma with adriamycin and dacarbazine(ADIC) and cyclophosphamide, vinblastine, adriamycin and dacarbazine(CYVADIC)
-
Park YS, Kang WK, Suh CI, Kim HT, Kim HJ, Park KC, Heo DS, Bang YJ, Kim NK
- KMID: 1742159
- J Korean Cancer Assoc.
- 1992 Jun;24(3):401-410.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Preliminary results of M-VAC(methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for advanced trasitional cell carcinoma of the urothelium
-
Jung SY, Kim SW, Yoon JY, Cho YH, Yoon MS, Lim SK
- KMID: 1912838
- Korean J Urol.
- 1991 Feb;32(1):31-36.
We reviewed retrospectively 23 patients treated with M-VAC (Methotrexate. Vinblastine, Doxorubicin, Cisplatin) from October 1987 to June 1990 at our hospital to evaluate predictive variables for response to chemotherapy and... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of M-VAC (Methotrexate, vinblastine, Doxorubicin and cisplatin) Chemotherapy for Metastatic Transitional Cell Carcinoma of the bladder Preliminary Report
-
Lee KS, Paick JS, Lee C, Kim SW
- KMID: 2289663
- Korean J Urol.
- 1990 Oct;31(5):648-654.
We treated 15 patients with metastatic transitional cell carcinoma with methotrexate, vinblastine, doxorubicin and cisplatin (M-VAC) chemotherapy. Median patient age was 58 years. The site of primary lesion was bladder... -
- CITED
-
- Close
- SHARE
-
- Close
- Preliminary Results of Neoadjuvant M-VAC(Methotrexate, Vinblastine, Adriamycin, Cisplatin) Chemotherapy for Bladder Carcinoma
-
Shin CS, Ryu SB
- KMID: 2139591
- Korean J Urol.
- 1990 Feb;31(1):59-64.
The trend in chemotherapy of bladder carcinoma has evolved from the single agent to the combination chemotherapy. In 1985 Sternberg et al. reported 71 per cent of significant tumor regression... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of M-VAC(Methotrexate, Vinblastine, Doxorubicin and Cisplatin) Regimen on Experimental Animal: Histopathological Study
-
Kim SJ, Kim WJ, Kim YK
- KMID: 2139584
- Korean J Urol.
- 1990 Feb;31(1):14-22.
Histopathologic study was performed to observe the effects of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin), widely used for advanced bladder cancer and its metastatic lesion, on the visceral organs of... -
- CITED
-
- Close
- SHARE
-
- Close
- M-VAC(Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Urothelial Tumors
-
Lee KS, Park CH, Lee SC
- KMID: 2289517
- Korean J Urol.
- 1989 Jun;30(3):340-344.
Patients with advanced urothelial tumors that relapse or persist following conventional therapy have poor prognosis. Management of the patients with recurrent local or disseminated urothelial tumors presents a difficult clinical... -
- CITED
-
- Close
- SHARE
-
- Close
